MedTrace Logo

Effect of HVLA vs MET on Shoulder Mobility and Pain in Adhesive Cpsulitis

NCT07600372 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 66

Last updated 2026-05-20

No results posted yet for this study

Summary

This study compared the effects of High-Velocity Low-Amplitude (HVLA) thrust and Post-Isometric Relaxation Muscle Energy Technique (PIR-MET) on pain and shoulder mobility in patients with adhesive capsulitis. Sixty-six participants received either HVLA or PIR-MET with conventional physiotherapy for four weeks. Both treatments improved pain and range of motion, but PIR-MET showed significantly greater improvement, making it a more effective approach for managing frozen shoulder symptoms.

Conditions

  • Adhesive Capsulitis

Interventions

BEHAVIORAL

High Velocity Low Amplitude Thrust

A manual therapy technique involving a quick, controlled thrust applied to the glenohumeral joint at the end of the available range of motion. The goal is to improve joint play and mobility. Each session lasted approximately 10-15 minutes. The intervention was performed 3 times per week for 12 weeks. Adverse events were monitored throughout the study.

BEHAVIORAL

Muscle Energy Technique

An active manual therapy technique where the patient contracts the shoulder muscles against the therapist's resistance, followed by a passive stretch. Target muscles included the posterior capsule, pectoralis major, and rotator cuff as indicated. Each session lasted approximately 15-20 minutes. The intervention was performed 3 times per week for 12 weeks.

Sponsors & Collaborators

  • Green International University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-11-09
Primary Completion
2026-04-29
Completion
2026-05-06

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07600372 on ClinicalTrials.gov